132 related articles for article (PubMed ID: 6210596)
1. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
Ginsburg CH; Falchuk ZM
Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
[TBL] [Abstract][Full Text] [Related]
2. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
4. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
5. T cell subpopulations in inflammatory bowel disease: evidence for a defective induction of T8+ suppressor/cytotoxic T lymphocytes.
Goronzy J; Weyand CM; Waase I
Clin Exp Immunol; 1985 Sep; 61(3):593-600. PubMed ID: 2934188
[TBL] [Abstract][Full Text] [Related]
6. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
Kemler BJ; Alpert E
Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
[TBL] [Abstract][Full Text] [Related]
7. Decreased suppressor cell activity in inflammatory bowel disease.
Hodgson HJ; Wands JR; Isselbacher KJ
Clin Exp Immunol; 1978 Jun; 32(3):451-8. PubMed ID: 308420
[TBL] [Abstract][Full Text] [Related]
8. Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.
Davidsen BD
Dan Med Bull; 1988 Jun; 35(3):201-22. PubMed ID: 2971513
[No Abstract] [Full Text] [Related]
9. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization.
Brogan MD; Shanahan F; Oliver M; Stevens RH; Targan SR
J Clin Lab Immunol; 1987 Oct; 24(2):69-74. PubMed ID: 3437440
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
[TBL] [Abstract][Full Text] [Related]
11. Impaired mixed-lymphocyte culture reactions in patients with inflammatory bowel disease.
Fiske SC; Falchuk ZM
Gastroenterology; 1980 Oct; 79(4):682-6. PubMed ID: 6447640
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease.
Ginsburg CH; Ault KA; Falchuk ZM
Gastroenterology; 1981 Dec; 81(6):1111-4. PubMed ID: 7026345
[TBL] [Abstract][Full Text] [Related]
13. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
[TBL] [Abstract][Full Text] [Related]
14. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
[TBL] [Abstract][Full Text] [Related]
15. Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.
Innes JB; Kuntz MM; Kim YT; Weksler ME
J Clin Invest; 1979 Dec; 64(6):1608-13. PubMed ID: 159315
[TBL] [Abstract][Full Text] [Related]
16. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
Victorino RM; Hodgson HJ
Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
[TBL] [Abstract][Full Text] [Related]
17. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.
Lyanga JJ; Davis P; Thomson AB
Clin Exp Immunol; 1979 Jul; 37(1):120-5. PubMed ID: 314871
[TBL] [Abstract][Full Text] [Related]
18. Decreased autologous mixed lymphocyte reaction in myasthenia gravis.
Richards I; Harrison R; Lunt GG; Bowen JG
J Clin Lab Immunol; 1986 May; 20(1):15-21. PubMed ID: 2942690
[TBL] [Abstract][Full Text] [Related]
19. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
[TBL] [Abstract][Full Text] [Related]
20. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
